The Relationship Between Plasma Magnesium Concentration and Hepatic Encephalopathy in Liver Cirrhosis Patients: A Preliminary Result of a Referral Center in Iran
| Author | Borna SafariKish | en |
| Author | Fereshteh Rafiei | en |
| Author | Armin Ebrahimi | en |
| Author | Fatemeh Azizi-Soleiman | en |
| Author | Rahmatollah Rafiei | en |
| Orcid | Borna SafariKish [0000-0002-5392-275X] | en |
| Orcid | Rahmatollah Rafiei [0000-0002-3673-5581] | en |
| Issued Date | 2022-04-30 | en |
| Abstract | Background: The present study aimed to assess the relationship between hepatic encephalopathy (HE) and serum magnesium concentration in patients with liver cirrhosis. Methods: The study population consisted of 90 cirrhotic patients admitted to the internal ward of Shariati Hospital, Isfahan, Iran. The patients were divided into two groups: with or without HE. Demographic data, cirrhosis aetiology, plasma concentration of magnesium, model end-stage liver disease (MELD) score, and Child-Pugh-Turcotte (CTP) class were recorded. Results: Thirty-one patients (34.4%) had hypomagnesaemia. Age and sex had no significant effects on plasma magnesium concentration (P-value = 0.134 and 0.212, respectively). The distribution of cirrhosis aetiologies was significantly different between patients with and without hypomagnesaemia (P-value = 0.005). Most patients with hypomagnesaemia were in groups B and C of CTP class (P = 0.027) and had a mean MELD score of 16.5 ± 5.8 versus 14.3 ± 5.4 in patients without hypomagnesaemia (P-value = 0.08). Hepatic encephalopathy was diagnosed in 45 (50.0%) patients. Mean serum levels of magnesium in patients with or without HE were 1.6 ± 0.2 and 1.9 ± 0.2 mEq/L, respectively (P-value < 0.001). There was no significant association between encephalopathy grade and serum magnesium concentration (P-value = 0.377). Conclusions: We demonstrated a relatively high prevalence of hypomagnesaemia among cirrhotic patients with HE. Hypomagnesaemia was associated with the severity of liver cirrhosis based on the Child-Pugh score. Prescription of magnesium supplements in cirrhotic patients may be helpful in preventing disease progression; however, further studies are needed. | en |
| DOI | https://doi.org/10.5812/mejrh-122978 | en |
| Keyword | Magnesium | en |
| Keyword | Liver Cirrhosis | en |
| Keyword | Hypomagnesaemia | en |
| Keyword | Hepatic Encephalopathy | en |
| Publisher | Brieflands | en |
| Title | The Relationship Between Plasma Magnesium Concentration and Hepatic Encephalopathy in Liver Cirrhosis Patients: A Preliminary Result of a Referral Center in Iran | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- mejrh-9-2-122978.pdf
- Size:
- 246.33 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF